311 related articles for article (PubMed ID: 16182375)
21. Amoebic gill disease and host response in Atlantic salmon (Salmo salar L.): A review.
Marcos-López M; Rodger HD
Parasite Immunol; 2020 Aug; 42(8):e12766. PubMed ID: 32564378
[TBL] [Abstract][Full Text] [Related]
22. A comparison of disease susceptibility and innate immune response between diploid and triploid Atlantic salmon (Salmo salar) siblings following experimental infection with Neoparamoeba perurans, causative agent of amoebic gill disease.
Chalmers L; Taylor JF; Roy W; Preston AC; Migaud H; Adams A
Parasitology; 2017 Aug; 144(9):1229-1242. PubMed ID: 28492111
[TBL] [Abstract][Full Text] [Related]
23. Cloning and functional characterisation of a peroxiredoxin 1 (NKEF A) cDNA from Atlantic salmon (Salmo salar) and its expression in fish infected with Neoparamoeba perurans.
Loo GH; Sutton DL; Schuller KA
Fish Shellfish Immunol; 2012 Jun; 32(6):1074-82. PubMed ID: 22450240
[TBL] [Abstract][Full Text] [Related]
24. Respiratory pathogenesis of amoebic gill disease (AGD) in experimentally infected Atlantic salmon Salmo salar.
Leef MJ; Harris JO; Powell MD
Dis Aquat Organ; 2005 Sep; 66(3):205-13. PubMed ID: 16261935
[TBL] [Abstract][Full Text] [Related]
25. In situ localisation of major histocompatibility complex class I and class II and CD8 positive cells in infectious salmon anaemia virus (ISAV)-infected Atlantic salmon.
Hetland DL; Jørgensen SM; Skjødt K; Dale OB; Falk K; Xu C; Mikalsen AB; Grimholt U; Gjøen T; Press CM
Fish Shellfish Immunol; 2010 Jan; 28(1):30-9. PubMed ID: 19766193
[TBL] [Abstract][Full Text] [Related]
26. Description of an Atlantic salmon (Salmo salar L.) type II interleukin-1 receptor cDNA and analysis of interleukin-1 receptor expression in amoebic gill disease-affected fish.
Morrison RN; Young ND; Nowak BF
Fish Shellfish Immunol; 2012 Jun; 32(6):1185-90. PubMed ID: 22433573
[TBL] [Abstract][Full Text] [Related]
27. Neoparamoeba sp. and other protozoans on the gills of Atlantic salmon Salmo salar smolts in seawater.
Bermingham ML; Mulcahy MF
Dis Aquat Organ; 2007 Jul; 76(3):231-40. PubMed ID: 17803109
[TBL] [Abstract][Full Text] [Related]
28. Oral L-cysteine ethyl ester (LCEE) reduces amoebic gill disease (AGD) in Atlantic salmon Salmo salar.
Roberts SD; Powell MD
Dis Aquat Organ; 2005 Aug; 66(1):21-8. PubMed ID: 16175964
[TBL] [Abstract][Full Text] [Related]
29. Immersion challenge of naïve Atlantic salmon with cultured Nolandella sp. and Pseudoparamoeba sp. did not increase the severity of Neoparamoeba perurans-induced amoebic gill disease (AGD).
English CJ; Botwright NA; Adams MB; Barnes AC; Wynne JW; Lima PC; Cook MT
J Fish Dis; 2021 Feb; 44(2):149-160. PubMed ID: 33314290
[TBL] [Abstract][Full Text] [Related]
30. Effects of gill abrasion and experimental infection with Tenacibaculum maritimum on the respiratory physiology of Atlantic salmon Salmo salar affected by amoebic gill disease.
Powell MD; Harris JO; Carson J; Hill JV
Dis Aquat Organ; 2005 Feb; 63(2-3):169-74. PubMed ID: 15819432
[TBL] [Abstract][Full Text] [Related]
31. Metabolic effects of amoebic gill disease (AGD) and chloramine-T exposure in seawater-acclimated Atlantic salmon Salmo salar.
Leef MJ; Harris JO; Powell MD
Dis Aquat Organ; 2007 Oct; 78(1):37-44. PubMed ID: 18159671
[TBL] [Abstract][Full Text] [Related]
32. Influence of salmonid gill bacteria on development and severity of amoebic gill disease.
Embar-Gopinath S; Butler R; Nowak B
Dis Aquat Organ; 2005 Nov; 67(1-2):55-60. PubMed ID: 16385808
[TBL] [Abstract][Full Text] [Related]
33. In vitro cultured Neoparamoeba perurans causes amoebic gill disease in Atlantic salmon and fulfils Koch's postulates.
Crosbie PB; Bridle AR; Cadoret K; Nowak BF
Int J Parasitol; 2012 May; 42(5):511-5. PubMed ID: 22549025
[TBL] [Abstract][Full Text] [Related]
34. Atlantic salmon, Salmo salar L., previously infected with Neoparamoeba sp. are not resistant to re-infection and have suppressed phagocyte function.
Gross KA; Morrison RN; Butler R; Nowak BF
J Fish Dis; 2004 Jan; 27(1):47-56. PubMed ID: 14986939
[TBL] [Abstract][Full Text] [Related]
35. Which Th pathway is involved during late stage amoebic gill disease?
Benedicenti O; Collins C; Wang T; McCarthy U; Secombes CJ
Fish Shellfish Immunol; 2015 Oct; 46(2):417-25. PubMed ID: 26166456
[TBL] [Abstract][Full Text] [Related]
36. Host-Parasite Interaction of Atlantic salmon (
Botwright NA; Mohamed AR; Slinger J; Lima PC; Wynne JW
Front Immunol; 2021; 12():672700. PubMed ID: 34135900
[TBL] [Abstract][Full Text] [Related]
37. Amoebic gill disease (AGD)-affected Atlantic salmon, Salmo salar L., are resistant to subsequent AGD challenge.
Vincent BN; Morrison RN; Nowak BF
J Fish Dis; 2006 Sep; 29(9):549-59. PubMed ID: 16948705
[TBL] [Abstract][Full Text] [Related]
38. Concentration effects of Winogradskyella sp. on the incidence and severity of amoebic gill disease.
Embar-Gopinath S; Crosbie P; Nowak BF
Dis Aquat Organ; 2006 Nov; 73(1):43-7. PubMed ID: 17240751
[TBL] [Abstract][Full Text] [Related]
39. Increased systemic vascular resistance in Atlantic salmon, Salmo salar L., affected with amoebic gill disease.
Leef MJ; Hill JV; Harris JO; Powell MD
J Fish Dis; 2007 Oct; 30(10):601-13. PubMed ID: 17850576
[TBL] [Abstract][Full Text] [Related]
40. Amoebic gill disease resistance is not related to the systemic antibody response of Atlantic salmon, Salmo salar L.
Taylor RS; Crosbie PB; Cook MT
J Fish Dis; 2010 Jan; 33(1):1-14. PubMed ID: 19943840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
